Lumpectomy is not advised if breast cancer returns

A mastectomy is prudent when breast cancer returns after a lumpectomy, because survival rates are higher for those who have another lumpectomy, according to a new study published in the American Journal of Surgery in October.

‘We were surprised to find that so many women in our study – almost a quarter – had received another lumpectomy rather than a mastectomy,’ said Dr Steven L Chen, from the University of California Davis Cancer Centre in Sacramento. ‘It’s likely that patients are asking for lumpectomies when their cancer is diagnosed a second time, and their doctors are simply complying with that request. Whatever the reason, that decision can shorten life spans.’
The study involved 747 women who had a same-breast cancer recurrence after undergoing breast conservation therapy. Of these patients 24% underwent a second lumpectomy. The five-year survival rate was 67% for women who had a lumpectomy compared with 78% for those who had mastectomies. Analysis confirmed that lumpectomy reduced the odds of survival by 50%.
‘As therapy for breast cancer becomes more targeted, and researchers come closer to identifying those factors that make some breast cancers more aggressive than others, we may have the option of recommending second, and even third lumpectomies in select cases in the future,’ said study co-author Dr Steven Martinez. ‘Until then, mastectomy remains the best option for women experiencing a same-breast recurrence of their breast cancer.’

20.11.2008

More on the subject:

Related articles

Photo

News • Triple-negative breast cancer

TNBC can become treatment-resistant in more ways than one

About 50% of triple-negative breast cancer (TNBC) patients develop resistance to therapy, significantly reducing the chances of survival. Researchers found there is more than one way this can happen.

Photo

News • Acellular dermal matrix for breast reconstruction

Injectable breast ‘implant’ as alternative to surgery

Researchers have developed a prototype injectable paste that could help restore breast volume after tumor removal, with less scarring and shorter healing time than current options.

Photo

News • Call for more informed decision

Hormone replacement therapy after breast cancer: a risk worth taking?

Breast cancer survivors are often discouraged from undergoing hormone replacement therapy (HRT) to alleviate menopause symptoms. Now, new research paints a more differentiated picture.

Subscribe to Newsletter